Related Experiment Videos
Monoclonal antibodies to native HIV type 1 reverse transcriptase and their interaction with enzymes from different
A S Rytting1, L Akerblom, J Albert
1Unit of Medical Genetics, Department of Genetics and Pathology, Uppsala University, BMC, Sweden.
AIDS Research and Human Retroviruses
|August 25, 2000
Summary
Mouse monoclonal antibodies (MAbs) targeting HIV-1 reverse transcriptase (RT) revealed significant immunological diversity among different HIV-1 subtypes. This diversity impacts antibody cross-reactivity and RT-capturing capabilities.
Area of Science:
- Virology
- Immunology
- Biochemistry
Background:
- Recombinant HIV-1 reverse transcriptase (RT) is a key target for therapeutic interventions.
- Understanding the immunological diversity of HIV-1 RT is crucial for developing effective diagnostics and treatments.
Purpose of the Study:
- To generate and characterize mouse anti-RT monoclonal antibodies (MAbs).
- To investigate the immunological differences between RTs from various HIV-1 subtypes.
Main Methods:
- Production of MAbs using recombinant HIV-1 subtype B RT and saponin adjuvant.
- Assays measuring RT polymerase inhibition and RT-capturing capacity.
- Evaluation of MAb cross-reactivity against 18 RTs from 9 HIV-1 subtypes.
Main Results:
- Identified 12 MAb clones inhibiting RT activity and 34 with high RT-capturing capacity.
- RT-inhibitory MAbs showed two distinct cross-reactivity patterns.
- MAbs with RT-capturing capacity exhibited greater diversity, with at least seven distinct cross-reactivity groups identified.
- Significant immunological variation was observed between RTs from different HIV-1 subtypes and even within the same subtype.
Conclusions:
- HIV-1 RTs display substantial immunological differences across subtypes.
- The characterized MAbs provide valuable tools for studying HIV-1 RT diversity.
- Findings highlight the complexity of HIV-1 evolution and its implications for antibody-based strategies.